Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms

Teneille Walker(Medical University of South Carolina), Paul Dent(Virginia Commonwealth University)
Molecular Pharmacology
May 30, 2009
Cited by 95


Related Papers